AI MARKET SCANNING

Biohaven Ltd.

AVG HISTORICAL GAP -0.66%
MAX GAP RECORD -6.25%
🔒 PRO INSTITUTIONAL AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡

SENTINEL HISTORICAL GAP VIEWER

// $BHVN
📊 1-YEAR TIMELINE (GAPS PLOTTED) 🔮 SIMULATE SETUP 🔒
Bullish Opening Gap Bearish Opening Gap T-1 Close Baseline

CATALYSTS & GAP HISTORY

Oct 29, 2026 Earnings Release 2026-10-29 (AFTER CLOSE (16:00))
-6.25%
Aug 10, 2026 Earnings Release 2026-08-10 (AFTER CLOSE)
-3.71%
May 05, 2026 Earnings Release 2026-05-05 (AFTER CLOSE)
+0.82%
Mar 02, 2026 Earnings Release 2026-03-02 (AFTER CLOSE)
-3.22%
Nov 10, 2025 Earnings Release 2025-11-10 (BEFORE OPEN)
+2.30%
Aug 11, 2025 Earnings Release 2025-08-11 (BEFORE OPEN)
-2.99%
May 12, 2025 Earnings Release 2025-05-12 (AFTER CLOSE)
+0.92%
Mar 03, 2025 Earnings Release 2025-03-03 (BEFORE OPEN)
-0.62%

VOLATILITY & GAP BIAS

AVG GAP MOVE 1.9%
Bullish Gaps (4)
Bearish Gaps (6)
Neutral / Flat (6)

QUANTITATIVE LIVE RADAR BLOTTER

Algorithmic execution stream for $BHVN

EXECUTIONS0 LOGS
STATUS🔒 ENCRYPTED
Execution Date Strategy & Setup Direction Execution Range Hold Time Net PnL
Radar monitoring: awaiting next setup.
🔒 Real-Time Strategy Telemetry Protected

Exact execution levels, Trailing Stops, and live bot signals are reserved for PRO members.

UNLOCK LIVE RADAR ⚡

📖 Intelligence Summary

Biohaven Ltd., a biopharmaceutical company, focuses on the discovery, development, and commercialization of treatments for immunology, neuroscience, and oncology therapeutic areas worldwide. It develops BHV-1300, which is in Phase 2 clinical trial to treat Graves' disease and rheumatoid arthritis; BHV-1400 that is in Phase 2 clinical trial for treating IgA…

NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗